News
-
-
-
-
PRESS RELEASE
Onco-Innovations Announces Closing of Private Placement
Onco-Innovations Limited closes non-brokered private placement, issuing 1,428,570 units for gross proceeds of $2,000,000. Funds to be used for corporate purposes and cancer research. Statutory hold period applies to securities issued -
-
-
-
PRESS RELEASE
Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology
Onco-Innovations collaborates with Nucro-Technics for preclinical drug development services focusing on PNKP Technology. Nucro-Technics initiates lab work under IND enabling program with advanced analytical methods based on LC-MS -
-